Target shares climbed on Friday, December 26, after a Financial Times report revealed that activist investor TOMS Capital is building a stake in the retailer. The news fueled optimism among investors that external pressure could accelerate strategic changes at Target, a company that has faced skepticism about the pace of transformation under new leadership.
According to a research note from Wolfe Research, the involvement of an activist investor could help drive a stronger “change narrative” for Target. Investors have expressed concern that early messaging from new CEO Michael Fiddelke suggests continuity rather than bold transformation, and activist engagement may help reshape market perception. Wolfe analyst Spencer Haunus emphasized that “perception is reality” in the stock market, even if fears about limited change under new management may be exaggerated.
Haunus noted that internal initiatives such as return-to-office mandates and layoffs could help jump-start the business, although the positive impact of these measures may take time to materialize in financial results. He described Target as being positioned for a potential “hope trade,” where investor sentiment improves ahead of measurable performance gains, similar to past examples like Dollar Tree, which saw shares surge amid activist involvement.
Target currently trades at roughly 13 times earnings, a valuation that reflects expectations among many investors for a possible earnings-per-share cut. Should those expectations prove overly pessimistic, the stock could appear more attractive on a relative basis. However, Wolfe Research also highlighted meaningful operational challenges. Price gaps in general merchandise need to be addressed, stores may require additional labor hours, and increased spending on merchandising and advertising could be necessary. While these investments may strengthen Target’s competitive position, they could weigh on free cash flow and earnings in the near term.
Importantly, Haunus cautioned against selling core assets such as Target’s real estate or brand, warning that activist pressure in that direction could raise long-term concerns. The stock initially jumped as much as 7% after the report before settling around a 3% gain, suggesting a cautiously optimistic but still measured response from investors.


Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Bank of America's $72.5M Epstein Settlement: What You Need to Know
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO 



